Does tirzepatide affect your period — and what's actually causing it?

The myth: tirzepatide directly interferes with reproductive hormones

The most common question our prescribers receive on this topic is whether tirzepatide itself acts on the hormones that govern the menstrual cycle. The short answer is no, not in any documented direct way. The Mounjaro Summary of Product Characteristics, published on the Electronic Medicines Compendium (eMC), does not list menstrual irregularity as a known side effect. GIP and GLP-1 receptors, the two pathways tirzepatide activates, are found in the gut, pancreas and brain, not in the ovaries or uterine lining in any clinically significant way that current research has established.

So when women report cycle changes after starting tirzepatide, attributing those changes to the medicine acting directly on reproductive hormones is almost certainly the wrong explanation. The more accurate picture involves what the medicine does very effectively: reduce body weight, often quite quickly.

Adipose tissue (body fat) is metabolically active. It converts androgens into oestrogen via a process called aromatisation. When body fat falls substantially over a short period, that oestrogen source falls too. The hypothalamus and pituitary gland, which regulate the hormonal cascade behind ovulation and menstruation, are sensitive to these shifts. The result can be cycles that run long, short, light, heavier than usual or temporarily absent. This is the same mechanism behind cycle disruption seen with other causes of rapid weight loss, including bariatric surgery and restrictive eating. It is biology, not the medicine interfering directly.

How significant and how lasting are these cycle changes on tirzepatide?

Most reported cycle irregularities tied to rapid weight loss tend to settle once the rate of weight change slows and the body adjusts to its new hormonal baseline. Women who want a fuller picture of how tirzepatide and periods interact over time will find that the evidence specific to tirzepatide and menstrual outcomes is still building, this is an area of active research rather than settled clinical guidance.

There is a separate consideration for women with polycystic ovary syndrome (PCOS). PCOS is strongly linked to insulin resistance and excess weight, and many women with the condition have irregular or absent periods as a baseline. Weight loss (including weight loss supported by a GLP-1 or dual GIP/GLP-1 medicine) can actually restore more regular ovulation in some women with PCOS. This is not a guaranteed outcome, and tirzepatide is not licensed or prescribed specifically to manage PCOS, but it is a real pattern clinicians observe. If you have PCOS, it is worth discussing the possibility of improved fertility with your prescriber before starting, particularly around contraception planning.

That last point leads to a practical concern: improved ovulation means improved fertility. Women who previously assumed irregular cycles meant low fertility risk should not drop contraception without medical advice simply because their cycle was unpredictable before treatment.

The contraception interaction you need to know about

This is where the evidence becomes specific and clinically important. The NHS England guidance on weight-management injections makes clear that women using combined oral contraceptives should use an additional non-oral method of contraception for the first four weeks of tirzepatide treatment and for four weeks after each dose increase. The mechanism is gastric emptying: tirzepatide slows how quickly the stomach moves its contents into the small intestine, and oral contraceptive pills rely on consistent absorption through that route. Slowed absorption may reduce contraceptive effectiveness.

A non-oral method means something like condoms, a progestogen implant, a hormonal or copper coil, or a progestogen-only injection, not another tablet. Scotland's NHS guidance notes the same interaction, and it applies regardless of whether you are using the combined pill for contraception, for cycle management or for both. Transdermal methods such as patches and rings also avoid the absorption issue. If you are unsure which method applies to you, your GP, a sexual health clinic or our prescribers can advise before you start.

There is no equivalent documented absorption concern with semaglutide (Wegovy), which uses a single GLP-1 pathway rather than the dual GIP/GLP-1 mechanism. If you are considering how tirzepatide compares to other options and oral contraception is a key factor, that distinction is worth raising in your consultation.

When to speak to a clinician about period changes

A single altered cycle at the start of tirzepatide treatment or after a dose increase is unlikely to need urgent investigation. Bodies take time to adjust. That said, certain patterns warrant a conversation with your GP or prescriber sooner rather than later, and women who are uncertain whether their experience is typical can read more about whether Mounjaro can affect your periods before deciding whether to seek further advice.

Speak to your GP if: periods stop entirely for three or more consecutive months (amenorrhoea), bleeding becomes unusually heavy or painful in a way that is new for you, spotting occurs between periods for more than a couple of cycles, or you have any reason to think you might be pregnant. If you are approaching perimenopause, it is also worth keeping in mind that tirzepatide treatment may overlap with natural hormonal changes that independently affect cycle regularity, and for more detail on this our page covering whether Mounjaro affects your period sets out what current evidence suggests. Disentangling the two is something your GP is best placed to do.

One practical note on timing: if you are planning a break in treatment (say over a holiday or because of a delivery gap around a bank holiday) your weight, appetite and cycle can all shift during even a short pause, and our guidance on how Mounjaro can affect your period is worth reviewing if you notice changes around those breaks. Questions about managing treatment consistently are something our FAQs cover, or you can reach the team through our contact page any day of the week.

If you are ready to explore whether tirzepatide is clinically suitable for you, the place to start is a free consultation where a prescriber reviews your full health picture, not an algorithm.